References
- Richardson K, Andrews RJ, Marriott MS, Tarbit MH, Troke PF. Correlation of in vitro and in vivo activity of azole anti-fungals. In vitro and in vivo Evaluation of Antifungal Agents, K Iwata, H Van Den Bossche. Elsevier, Amsterdam 1986; 147–149, In
- Knight AG. Culture of dermatophytes upon stratum corneum. J Invest Dermatol 1973; 59: 427–431
- Gip L. The in vitro determination of lingering antimycotic effect of two 1% omoconazole-nitrate cream formulations following single topical application. Mycoses 1988; 31: 155–158
- Rurangirwa A, Piérard-Franchimont C, Piérard GE. Culture of fungi on cyanoacylate skin surface strippings. A quantitative bioassay for evaluating antifungal drugs. Clin Exp Dermatol 1989; 14: 425–428
- Grant SM, Clissold SP. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs 1989; 37: 310–344
- Woestenborghs R, Lorreyne W, Heykants J. Determination of itraconazole in plasma and animal tissues by high-performance liquid chromatography. J Chromat—Biomed Appl 1987; 413: 332–337
- Piérard GE, Rurangirwa A, Piérard-Franchimont C. Bioavailability of fluconazole and ketoconazole in human stratum corneum and oral mucosa. Clin Exp Dermatol 1991; 16: 168–171
- Piérard GE, Piérard-Franchimont C, Arrese Estrada J. Comparative study of the active and lingering effect of topical antifungals. Skin Pharmacol 1993; 6: 208–214
- Rurangirwa A, Piérard-Franchimont C, Piérard GE. Growth of Candida albicans on the stratum corneum of diabetic and non-diabetic patients. Mycoses 1990; 33: 253–255